Suchergebnisse - "O3J8G9O825"

PubPharm (5.509)

51

Physiologically based pharmacokinetic modeling of ritonavir-oxycodone drug interactions and its implication for dosing strategy

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2024

von Zheng, L. | Zhang, W. | Olkkola, K. | +6

52

Nirmatrelvir/ritonavir and pharmacovigilance data

enthalten in: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease | 2024

von Lassan, S. | Gocova, M. | Solovic, I. | +3

53

Cost-Effectiveness of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the United States

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2024

von Carlson, J. | Foos, V. | Kasle, A. | +7

54

Modulation of Multidrug Resistance Protein 1-mediated Transport Processes by the Antiviral Drug Ritonavir in Cultured Primary Astrocytes

enthalten in: Neurochemical research | 2024

von Arend, C. | Grothaus, I. | Waespy, M. | +2

55

Effect of Hepatic Impairment on the Pharmacokinetics of Nirmatrelvir/Ritonavir, the First Oral Protease Inhibitor for the Treatment of COVID-19

enthalten in: Journal of clinical pharmacology | 2024

von Singh, R. | LaBadie, R. | Toussi, S. | +4

56

Effect of pre-hospitalization use of oral antiviral agents on reducing critical illness and mortality for patients with COVID-19 pneumonia

enthalten in: International journal of antimicrobial agents | 2024

von Yii, Y. | Shih, H. | Chen, C. | +5

57

In outpatients with COVID-19 during Omicron variant circulation, molnupiravir and nirmatrelvir-ritonavir improved outcomes

enthalten in: Annals of internal medicine | 2024

von Chagla, Z.

CommentOn: Ann Intern Med. 2023 Oct;176(10):1377-1385. - PMID 37722115

58

Coadministration of ABCB1/P-glycoprotein inhibitor elacridar improves tissue distribution of ritonavir-boosted oral cabazitaxel in mice

enthalten in: International journal of pharmaceutics | 2024

von Loos, N. | Martins, M. | de Jong, D. | +4

59

Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro

enthalten in: Antiviral research | 2024

von Gallucci, L. | Bazire, J. | Davidson, A. | +1

60

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19

enthalten in: The New England journal of medicine | 2024

von Cao, B. | Wang, Y. | Lu, H. | +28